Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BABY

Natus Medical (BABY) Stock Price, News & Analysis

Natus Medical logo

About Natus Medical Stock (NASDAQ:BABY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$26.75
$31.92
52-Week Range
N/A
Volume
22 shs
Average Volume
165,325 shs
Market Capitalization
$1.12 billion
P/E Ratio
23.21
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Natus Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

BABY MarketRank™: 

Natus Medical scored higher than 44% of companies evaluated by MarketBeat, and ranked 604th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Natus Medical.

  • Earnings Growth

    Earnings for Natus Medical are expected to grow by 24.41% in the coming year, from $1.27 to $1.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Natus Medical is 23.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.94.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Natus Medical is 23.21, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.03.

  • Short Interest

    There is no current short interest data available for BABY.
  • Dividend Yield

    Natus Medical does not currently pay a dividend.

  • Dividend Growth

    Natus Medical does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for BABY.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Natus Medical this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for BABY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Natus Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.65% of the stock of Natus Medical is held by insiders.

  • Percentage Held by Institutions

    91.56% of the stock of Natus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Natus Medical's insider trading history.
Receive BABY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

BABY Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

BABY Stock Analysis - Frequently Asked Questions

Natus Medical Inc (NASDAQ:BABY) issued its quarterly earnings data on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing analysts' consensus estimates of $0.42 by $0.02. The company's quarterly revenue was up 6.5% compared to the same quarter last year.

Natus Medical (BABY) raised $9 million in an initial public offering on Wednesday, March 8th 2023. The company issued 1,766,618 shares at a price of $5.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natus Medical investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), Starbucks (SBUX), Intel (INTC), Walt Disney (DIS), Gilead Sciences (GILD) and Activision Blizzard (ATVI).

Company Calendar

Last Earnings
10/24/2018
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:BABY
Fax
N/A
Employees
1,729
Year Founded
N/A

Profitability

Trailing P/E Ratio
23.21
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.93 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$530.89 million
Price / Cash Flow
9.39
Book Value
$11.80 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.12 billion
Optionable
Optionable
Beta
0.57
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:BABY) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners